SMS Lifesciences India Limited

NSEI:SMSLIFE Voorraadrapport

Marktkapitalisatie: ₹3.2b

SMS Lifesciences India Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

SMS Lifesciences India heeft een totaal eigen vermogen van ₹2.0B en een totale schuld van ₹894.9M, wat de schuld-eigenvermogensverhouding op 44% brengt. De totale activa en totale passiva bedragen respectievelijk ₹3.9B en ₹1.9B. De EBIT SMS Lifesciences India is ₹307.4M waardoor de rentedekking 3.3 is. Het heeft contanten en kortetermijnbeleggingen van ₹11.9M.

Belangrijke informatie

44.0%

Verhouding schuld/eigen vermogen

₹894.94m

Schuld

Rente dekkingsratio3.3x
Contant₹11.92m
Aandelen₹2.03b
Totaal verplichtingen₹1.88b
Totaal activa₹3.91b

Recente financiële gezondheidsupdates

Recent updates

Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive

Nov 14
Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive

Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Aug 27
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Aug 01
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

Jun 13
SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market

SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

Feb 10
SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky

There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Jan 05
There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump

Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

Sep 23
Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?

SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

Sep 07
SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

Aug 24
SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 16
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

Sep 02
SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50

SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

Jun 03
SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt

With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

May 13
With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting

SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Nov 23
SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals

Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Jun 21
Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?

Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

Feb 22
Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?

SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Jan 04
SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Nov 27
Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares

Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

Nov 24
Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₹1.5B ) SMSLIFE } overtreffen de korte termijn passiva ( ₹1.4B ).

Langlopende schulden: De kortetermijnactiva SMSLIFE ( ₹1.5B ) overtreffen de langetermijnschulden ( ₹441.0M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 43.4% ) SMSLIFE wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van SMSLIFE is de afgelopen 5 jaar gestegen van 42% naar 44%.

Schuldendekking: De schuld van SMSLIFE wordt goed gedekt door de operationele kasstroom ( 37.4% ).

Rentedekking: De rentebetalingen op de schuld van SMSLIFE worden goed gedekt door EBIT ( 3.3 x dekking).


Balans


Ontdek gezonde bedrijven